Corcept Therapeutics reported $31.69M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Alaunos Therapeutics USD -7843000 633K Dec/2023
ANI Pharmaceuticals USD 10.52M 9.47M Jun/2025
Ardelyx USD -19080000 23.76M Jun/2025
Aurora Cannabis CAD -19380000 51.45M Jun/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Canopy Growth CAD -41240000 80.34M Jun/2025
Corcept Therapeutics USD 31.69M 22.07M Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
J&J USD 13.63B 8.21B Mar/2025
Knight Therapeutics CAD -7144000 19.01M Mar/2024
Merck USD 6.77B 864M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Novartis USD 4.53B 133M Jun/2025
Pacira USD -1927000 10.63M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Supernus Pharmaceuticals USD 16.67M 22.5M Jun/2025
TG Therapeutics USD 30.92M 25.45M Jun/2025